ID 102832
Title Transcription
トクシマ コウケツアツ トウニョウビョウ study 2011 : コウケツアツ トウニョウビョウ ガッペイ レイ ニ カンスル タシセツ ケンキュウ
Author
Nishiuchi, Takeshi Kawashima Hospital
Nagase, Norio National Hospital Organization Higashi Tokushima Medical Center
Komatsu, Machiko Kawashima Hospital
Fukushima, Yasue Fukushima Internal Medicine
Okushi, Hidesato Okushi Cardiovascular Clinic
Mitani, Hiroaki Mitani Clinic
Yata, Kentaro Yata Clinic
Akaike, Masashi Depart of Medical Education, Institute of Health Biosciences,University of Tokushima Graduate School Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Hiasa, Yoshikazu Tokushima Red Cross Hospital
Keywords
diabetes mellitus
hypertension
antihypertensive therapy
antidiabetes therapy
risk factor
choresterol level
Content Type
Journal Article
Description
Cardiologists and diabetologists in Tokushima Prefecture investigated patients with hypertension and diabetes mellitus on treatment in2011. The findings were compared with our year‐2004 data. The study population comprised 236 patients with hypertension and diabetes mellitus being treated by cardiologists(C2011group), and 395 patients with the same condition being treated by diabetologists(D2011group). The mean number of antihypertensives used per patient was1.9for the C2011group and1.6for the D2011group. In these two groups, calcium antagonists were the most frequently used drugs. Renin-angiotensin system(RAS)inhibitors were used in71.5% of the patients in the C2011group and70.0% in the D2011group. The ratio of patients meeting the blood pressure criteria of the Japan Hypertension Society Guidelines was 21.6% for the C2004group,22.9% for the D2004group,29.1% for the C2011group, and18.2% for the D2011group. The mean number of antidiabetics used per patient was1.3for the two groups, glimepiride being most frequently used(38.5% for the C2011group,58.1% for the D2011group), followed by α-glucosidase inhibitors and pioglitazone. Frequency of use of biguanide increased compared with2004. The ratio of patients with HbA1c<6.5% was40.7% for the C2004group, 21.9% for the D2004 group, 46.5% for the C2011 group, and 49.0% for the D2011 group ; a significant improvement was observed in the D2011group compared with the D2004group. The serum cholesterol control rate was49.7% for the C2004group,45.0% for the D2004group,60.9% for the C2011group, and56.5% for the D2011group. The ratio of patients achieving good control for all three parameters(blood pressure, blood glucose level, serum lipid level)was low at7.6% for the C2004group,6.7% for the D2004group,9.4% for the C2011group, and9.0% for the D2011 group. This managerial situation for the condition is unsatisfactory, necessitating efforts for even better control.
Journal Title
四国医学雑誌
ISSN
00373699
NCID
AN00102041
Publisher
徳島医学会
Volume
68
Issue
3-4
Start Page
111
End Page
118
Sort Key
111
Published Date
2012-08-25
Remark
FullText File
language
jpn
departments
Medical Sciences